Cantargia AB (publ) (CANTA.ST)

SEK 1.83

(1.05%)

Eps Summary of Cantargia AB (publ)

  • Cantargia AB (publ)'s latest annual eps in 2023 was -1.65 SEK , up 41.7% from previous year.
  • Cantargia AB (publ)'s latest quarterly eps in 2024 Q2 was -0.24 SEK , down -20.0% from previous quarter.
  • Cantargia AB (publ) reported an annual eps of -2.83 SEK in 2022, up 22.68% from previous year.
  • Cantargia AB (publ) reported an annual eps of -3.66 SEK in 2021, down -127.33% from previous year.
  • Cantargia AB (publ) reported a quarterly eps of -0.20 SEK for 2024 Q1, up 50.0% from previous quarter.
  • Cantargia AB (publ) reported a quarterly eps of -0.46 SEK for 2023 Q3, down -35.29% from previous quarter.

Annual Eps Chart of Cantargia AB (publ) (2023 - 2011)

Historical Annual Eps of Cantargia AB (publ) (2023 - 2011)

Year Eps Eps Growth
2023 -1.65 SEK 41.7%
2022 -2.83 SEK 22.68%
2021 -3.66 SEK -127.33%
2020 -1.61 SEK -24.81%
2019 -1.29 SEK -12.17%
2018 -1.15 SEK 25.81%
2017 -1.55 SEK 27.23%
2016 -2.13 SEK -113.0%
2015 -1.00 SEK -104.08%
2014 -0.49 SEK -4.26%
2013 -0.47 SEK -135.0%
2012 -0.20 SEK 0.0%
2011 -0.20 SEK 0.0%

Peer Eps Comparison of Cantargia AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -200.0%
Ziccum AB (publ) -1.54 SEK -7.143%
Modus Therapeutics Holding AB (publ) -1.01 SEK -63.366%
BioArctic AB (publ) 2.60 SEK 163.462%
Sprint Bioscience AB (publ) -0.01 SEK -26090.476%
Mendus AB (publ) -4.40 SEK 62.5%
Genovis AB (publ.) 0.94 SEK 275.532%
Intervacc AB (publ) -1.69 SEK 2.367%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -650.0%
Active Biotech AB (publ) -0.17 SEK -870.588%
Magle Chemoswed Holding AB (publ) 1.13 SEK 246.018%
Bio-Works Technologies AB (publ) -1.57 SEK -5.096%
Aptahem AB (publ) -0.05 SEK -3316.149%
Vicore Pharma Holding AB (publ) -3.22 SEK 48.758%
Kancera AB (publ) -0.80 SEK -106.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 83.417%
Fluicell AB (publ) -0.24 SEK -587.5%
Saniona AB (publ) -1.29 SEK -27.907%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -768.421%
Biovica International AB (publ) -2.14 SEK 22.897%
Spago Nanomedical AB (publ) -0.43 SEK -283.721%
AcouSort AB (publ) -1.29 SEK -27.907%
Xintela AB (publ) -0.13 SEK -1169.231%
Abliva AB (publ) -0.09 SEK -1725.221%
Egetis Therapeutics AB (publ) -1.27 SEK -29.921%
Karolinska Development AB (publ) 0.02 SEK 8350.0%
OncoZenge AB (publ) -1.36 SEK -21.324%
Amniotics AB (publ) -0.01 SEK -14900.0%
2cureX AB (publ) -1.85 SEK 10.811%
CombiGene AB (publ) -1.80 SEK 8.333%
Asarina Pharma AB (publ) -0.57 SEK -189.474%
Calliditas Therapeutics AB (publ) -8.69 SEK 81.013%
Camurus AB (publ) 7.78 SEK 121.208%
Corline Biomedical AB -0.08 SEK -1859.62%
IRLAB Therapeutics AB (publ) -3.43 SEK 51.895%
Isofol Medical AB (publ) -0.23 SEK -617.391%
I-Tech AB 1.70 SEK 197.059%
Hansa Biopharma AB (publ) -15.83 SEK 89.577%
Cyxone AB (publ) -0.22 SEK -650.0%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 16.667%
Biosergen AB -0.60 SEK -175.0%
NextCell Pharma AB -1.03 SEK -60.194%
Xspray Pharma AB (publ) -6.76 SEK 75.592%
Elicera Therapeutics AB (publ) -0.83 SEK -98.795%
Nanologica AB (publ) -2.05 SEK 19.512%
SynAct Pharma AB -6.64 SEK 75.151%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -534.615%
Stayble Therapeutics AB (publ) -0.92 SEK -79.348%
LIDDS AB (publ) -0.63 SEK -161.905%
Lipum AB (publ) -4.45 SEK 62.921%
BioInvent International AB (publ) -5.02 SEK 67.131%
Alzinova AB (publ) -0.41 SEK -302.439%
Oncopeptides AB (publ) -1.96 SEK 15.816%
Pila Pharma AB (publ) -0.47 SEK -251.064%
Guard Therapeutics International AB (publ) -11.26 SEK 85.346%
Scandinavian ChemoTech AB (publ) -1.13 SEK -46.018%
Simris Alg AB (publ) -0.16 SEK -931.25%
Diamyd Medical AB (publ) -1.60 SEK -3.125%
Xbrane Biopharma AB (publ) -1.27 SEK -29.921%
Ascelia Pharma AB (publ) -3.24 SEK 49.074%
Diagonal Bio AB (publ) -0.32 SEK -415.625%